全文获取类型
| 收费全文 | 2020篇 |
| 免费 | 265篇 |
| 国内免费 | 10篇 |
专业分类
| 耳鼻咽喉 | 18篇 |
| 儿科学 | 98篇 |
| 妇产科学 | 65篇 |
| 基础医学 | 348篇 |
| 口腔科学 | 29篇 |
| 临床医学 | 327篇 |
| 内科学 | 403篇 |
| 皮肤病学 | 36篇 |
| 神经病学 | 75篇 |
| 特种医学 | 127篇 |
| 外科学 | 177篇 |
| 综合类 | 92篇 |
| 一般理论 | 2篇 |
| 预防医学 | 233篇 |
| 眼科学 | 6篇 |
| 药学 | 104篇 |
| 1篇 | |
| 中国医学 | 20篇 |
| 肿瘤学 | 134篇 |
出版年
| 2022年 | 14篇 |
| 2021年 | 35篇 |
| 2020年 | 27篇 |
| 2019年 | 34篇 |
| 2018年 | 32篇 |
| 2017年 | 29篇 |
| 2016年 | 26篇 |
| 2015年 | 60篇 |
| 2014年 | 59篇 |
| 2013年 | 79篇 |
| 2012年 | 97篇 |
| 2011年 | 112篇 |
| 2010年 | 95篇 |
| 2009年 | 80篇 |
| 2008年 | 100篇 |
| 2007年 | 116篇 |
| 2006年 | 81篇 |
| 2005年 | 64篇 |
| 2004年 | 59篇 |
| 2003年 | 85篇 |
| 2002年 | 67篇 |
| 2001年 | 57篇 |
| 2000年 | 48篇 |
| 1999年 | 39篇 |
| 1998年 | 41篇 |
| 1997年 | 34篇 |
| 1996年 | 49篇 |
| 1995年 | 36篇 |
| 1994年 | 43篇 |
| 1993年 | 32篇 |
| 1992年 | 36篇 |
| 1991年 | 36篇 |
| 1990年 | 36篇 |
| 1989年 | 40篇 |
| 1988年 | 38篇 |
| 1987年 | 27篇 |
| 1986年 | 30篇 |
| 1985年 | 28篇 |
| 1984年 | 25篇 |
| 1983年 | 22篇 |
| 1982年 | 17篇 |
| 1981年 | 16篇 |
| 1980年 | 22篇 |
| 1979年 | 30篇 |
| 1978年 | 25篇 |
| 1976年 | 22篇 |
| 1975年 | 20篇 |
| 1974年 | 11篇 |
| 1973年 | 17篇 |
| 1972年 | 14篇 |
排序方式： 共有2295条查询结果，搜索用时 15 毫秒
51.
Bernard Salame Gemaque Alex Junior Souza de Souza Manoel do Carmo Pereira Soares Andreza Pinheiro Malheiros Andrea Lima Silva Max Moreira Alves Michele Soares Gomes-Gouvêa Jo?o Renato Rebello Pinho Heriberto Ferreira de Figueiredo Djacy Barbosa Ribeiro Jonan Souza da Silva Leopoldo Augusto Moraes Ana Silvia Sardinha Ribeiro Washington Luiz Assun??o Pereira 《Emerging infectious diseases》2014,20(12):2180-2182
52.
53.
54.
55.
Adil A. Shah Umar F. Bhatti Mikael Petrosyan George Washington Wasay Nizam Mallory Williams Daniel Tran Edward E. Cornwell Terrence M. Fullum 《American journal of surgery》2019,217(4):732-738
Background
Laparoscopic cholecystectomy (LC) is the standard operative intervention for gallbladder disease. Complications may necessitate conversion to an open cholecystectomy (OC). This study aims to determine the cost-consequences of laparoscopic-to-open conversion using a nationally-representative sample.Methods
Using the National Inpatient Sample (2007–2011), adult patients undergoing emergent LC were identified. Patients undergoing secondary-conversion to OC were subsequently identified. Multivariable regression analyses, accounting for differences in propensity-quintile, mortality, length of stay, and hospital-level factors were then performed to assess for differences in the odds of conversion and total predicted mean costs per index-hospitalization.Results
Of 225,805 observations, conversion to open occurred in 1.86% (n?=?4203) of cases. Increased age, African-American ethnicity, public-insurance and teaching-hospital status were associated with a higher likelihood of conversion (p?<?0.05) after risk-adjustment. Risk-adjusted odds of conversion increased by 34% (95%CI:1.33–1.36) for each day surgery was delayed. Risk-adjusted costs, were 259% higher (absolute-difference $23,358,p?<?0.05) with conversion. Mortality was higher amongst patients undergoing conversion to open (4.98% vs 0.34%,p?<?0.001).Conclusion
Patients undergoing conversion from laparoscopic to open cholecystectomy are at an increased risk of receiving disparate care and increased mortality. 相似文献56.
57.
58.
59.
Sequence variants in nine different genes underlying rare skin disorders in 10 consanguineous families 
下载免费PDF全文
下载免费PDF全文 Khadim Shah MPhil Sabba Mehmood MPhil Abid Jan PhD Izoduwa Abbe MS Raja Hussain Ali PhD Anwar Khan MPhil Muhammad S. Chishti PhD Kwanghyuk Lee MPhil Farooq Ahmad MPhil Muhammad Ansar PhD University of Washington Center for Mendelian Genomics Shaheen Shahzad PhD Deborah A. Nickerson PhD Michael J. Bamshad MD Paul J. Coucke PhD Regie L. P. Santos‐Cortez MD PhD Richard A. Spritz MD Suzanne M. Leal PhD Wasim Ahmad PhD 《International journal of dermatology》2017,56(12):1406-1413
60.
TA Luger 《Journal of the European Academy of Dermatology and Venereology》2011,25(3):251-258
Although emollients can be sufficient to manage mild atopic dermatitis (AD), acute flares resulting in moderate‐to‐severe symptoms require treatment with anti‐inflammatory agents, such as topical corticosteroids (TCs) and topical calcineurin inhibitors (TCIs). This review examines the role of a member of the newest class of TCs, the fourth‐generation compound methylprednisolone aceponate (MPA) in AD management, with reference to the chemical structure, pharmacokinetics, efficacy in AD, safety assessed in preclinical and clinical trials and dosing considerations. MPA has an optimized efficacy/safety profile with minimal local or systemic adverse effects. In addition, it offers the opportunity for once‐daily dosing, which provides benefits in terms of patient compliance with treatment. 相似文献